Day: July 14, 2022

NEWARK, N.Y., July 14, 2022 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2022, before the market opens on Thursday, July 28, 2022. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on July 28, 2022. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A live webcast of the conference call will be available to investors in the Events & Presentations Section of the Company’s website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location. About Ultralife Corporation Ultralife...

Amryt Receives Orphan Drug Designation from the FDA for Mycapssa® (oral octreotide) for the Treatment of Carcinoid Syndrome DUBLIN, Ireland, and Boston MA, July 14, 2022, Amryt (Nasdaq: AMYT), a global, commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing novel treatments for rare diseases, is pleased to announce that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to Mycapssa® for the treatment of carcinoid syndrome. Carcinoid syndrome (CS) is the most common functional syndrome associated with neuroendocrine tumours (NETs). The Orphan Drug Designation program provides orphan status to drugs and biologics, which are defined as those intended for the safe and effective treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000...

Hamilton, Bermuda, July 14, 2022 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog” or the “Company”) (NYSE: GLOG PRA) today announced the availability of the Company’s 2021 Sustainability Report.  The Sustainability Report, which can be accessed on the Company’s website, has been compiled in general compliance with the Sustainability Accounting Standards Board (“SASB”) Marine Transportation standard.  In the Report, GasLog summarizes progress delivered around the focus areas of decarbonization, safety and wellbeing, and diversity, equity and inclusion, among other areas. GasLog 2021 Sustainability Report: www.gaslogltd.com/investors/sustainability/ Contacts: Alex PapadimitriouEmail: ir@gaslogltd.com About GasLog GasLog is an international owner, operator and manager of LNG carriers providing support to international energy companies as...

20220714 Bihor Sud exploration map Map of the exploration license in Bihor SudVancouver, July 14, 2022 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) is pleased to report that it has received confirmation that the National Agency for Mineral Resources (“NAMR”) has approved the first-year exploration program (the “Exploration Program”) for the Bihor Sud exploration license (the “Project”). Highlights:Exploration to focus on surface mapping and re-opening historical galleries Rock grab samples from mine dumps report grades up to 6.8% Cobalt and 28% NickelThe Exploration Program covers a number of initial exploration activities to validate the geological potential of the Project and further build on information acquired under the earlier prospecting...

BROOMFIELD, Colo., July 14, 2022 (GLOBE NEWSWIRE) — DMC Global Inc. (Nasdaq: BOOM) will announce its 2022 second quarter financial results after the stock market closes on Thursday, August 4, 2022.  Following the earnings release, executive management will host a conference call and simultaneous webcast. The conference call will begin at 5 p.m. Eastern (3 p.m. Mountain) and will be accessible by dialing 888-506-0062 (973-528-0011 for international callers) and entering the code 762205. A telephonic replay will be available through August 11, 2022, by calling 877-481-4010 (919-882-2331 for international callers) and entering the Conference ID #46132. Investors are invited to listen to the webcast live via the Internet at: https://www.webcaster4.com/Webcast/Page/2204/46132 The webcast also will be available on the Investor page...

BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the second quarter of fiscal 2022 before U.S. markets open on Tuesday, August 9, 2022. SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:30 a.m. EDT / 2:30 p.m. CEST. The call will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the website after its completion. About SOPHiA GENETICS SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform,...

HydroGraph is Now Producing Graphene at Volume TORONTO, July 14, 2022 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (HG.CN) (the “Company” or “HydroGraph”), a commercial manufacturer of high-quality nanomaterials and alternative-energy fuels, has launched its patented graphene ink, an entirely new and novel form of “conductive ink” that maintains the valuable qualities of graphene including strength, non-toxicity, flexibility, and optical transparency. As the name suggests, conductive ink is a material that conducts energy with the utility of an ink. This development marks a significant step toward the production of inexpensive, foldable, and wearable electronics. “This is a significant milestone in renewable technology production. From touch screen displays, biosensors, radio frequency identification tags, electric vehicle batteries,...

The US is expected to retain its position as the largest market for glioblastoma multiforme in 2030 LONDON, July 14, 2022 (GLOBE NEWSWIRE) — The “Glioblastoma Multiforme: Global Drug Forecast and Market Analysis to 2030” report offered by GlobalData provide opportunities for various marketed agents and pipeline agents in development across the 8MM, clinical and commercial assessments for agents in late-stage clinical development, R&D strategies, and innovative approaches in development for glioblastoma multiforme. The total sales of glioblastoma multiforme (GBM) therapies was estimated to be $549.1 million in 2020 across the 8MM and is expected to increase at a CAGR of more than 4% by 2030. The market growth will be driven by the anticipated launch of eight pipeline agents, of which cancer vaccines and protein kinase inhibitors...

TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF JUNE 2022 VANCOUVER, BC, CANADA, July 14, 2022 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) is pleased to provide a construction update for the month of June 2022. During the month of June, the Company completed twenty-two (22) new towers: eleven (11) towers in Colombia, ten (10) towers in Ecuador, and one (1) tower in Mexico with a total of fifty-one (51) towers under construction in these specific countries, as well. These towers are built to suit for specific clients and will provide a total, non-cancellable rent revenue for 10 years of approximately $2,600,000 (*This figure excludes colocation revenue upside and inflation escalator terms). Tower One began the year with 204 towers in operation and as of June...